Strides Pharma Science Limited — JV/Acquisition, 25-10-2024: Acquisition

Strides Pharma Global Pte Limited is acquiring the remaining 30% stake in Strides Pharma International AG (Strides Switzerland) for approximately CHF 1.01 million, consolidating its ownership to 100%. This strategic move enhances operational synergy and strengthens Strides' position in the European pharmaceutical market. Oren Weininger will continue as CEO, ensuring continuity in leadership. The acquisition reflects Strides' ongoing commitment to expanding its European B2B business.